Table 2.
Characteristics | OS (%) | P | DFS (%) | P |
---|---|---|---|---|
Gender | 0.668 | 0.001 | ||
Male | 96.7 | 67.9 | ||
Female | 97.7 | 82.5 | ||
Patients’ age (years) | <0.001 | <0.001 | ||
<45 | 98.8 | 85.8 | ||
≥45 | 94.2 | 66.5 | ||
Primary tumor size (cm) | 0.002 | <0.001 | ||
≤1 | 100 | 91.5 | ||
>1 and ≤2 | 100 | 89.2 | ||
>2 and ≤4 | 96.8 | 79.9 | ||
>4 | 90.3 | 40.3 | ||
Lymph node status | <0.001 | <0.001 | ||
N0 | 100 | 94.9 | ||
N1 | 91.8 | 49.1 | ||
Development of DM | <0.001 | – | – | |
No | 98.6 | |||
Positive | 63.2 | |||
Extrathyroid extension | <0.001 | <0.001 | ||
No | 98 | 82 | ||
Probable | 84.4 | 28 | ||
Multifocality | 0.94 | 0.002 | ||
No | 97 | 79.9 | ||
Yes | 94.1 | 55.9 | ||
Subtypes | 0.15 | 0.642 | ||
Classic | 98 | 98 | ||
Follicular | 94.4 | 94.4 | ||
Others* | 100 | 100 |
*, Including encapsulated tall and columnar cell variants. PTC, papillary thyroid carcinoma; OS, overall survival; DFS, disease-free survival; DM, distant metastasis.